Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
Ali S. OmraniDivision of Infectious Diseases, Prince Sultan Military Medical City, Riyadh, Saudi ArabiaMustafa SaadDivision of Infectious Diseases, Prince Sultan Military Medical City, Riyadh, Saudi ArabiaKamran BaigDepartment of Infection Prevention and Control, Prince Sultan Military Medical City, Riyadh, Saudi ArabiaAbdelkarim BahloulDivision of Infectious Diseases, Prince Sultan Military Medical City, Riyadh, Saudi ArabiaMohammed Abdul-MatinDepartment of Medicine, Prince Sultan Military Medical City, Riyadh, Saudi ArabiaAmal Y.A. Al-AidaroosDivision of Infectious Diseases, Prince Sultan Military Medical City, Riyadh, Saudi Arabia; Department of Infection Prevention and Control, Prince Sultan Military Medical City, Riyadh, Saudi ArabiaGhaleb A AlmakhlafiDepartment of Critical Care, Prince Sultan Military Medical City, Riyadh, Saudi ArabiaMohammed M. AlbarrakDepartment of Critical Care, Prince Sultan Military Medical City, Riyadh, Saudi ArabiaZiad A. MemishAl-Faisal University and Ministry of Health, Riyadh, Saudi Arabia. Electronic address: [email protected]Ali AlbarrakDivision of Infectious Diseases, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
2014en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
3 та иқтибос0 та фойдаланилган манба